The United States represents one of the world’s most attractive markets for health, wellness, skincare, and personal care products. However, many companies are surprised to discover that certain products commonly marketed as cosmetics in other regions may be classified differently in the United States.
When a product claims to prevent disease, treat medical conditions, or affect the structure or function of the body, it may fall under the category of an Over-the-Counter (OTC) drug rather than a cosmetic. This distinction is critical because OTC products are subject to significantly more demanding regulatory requirements enforced by the US Food and Drug Administration (FDA).
Understanding these requirements is essential for manufacturers, brand owners, and distributors seeking successful market access in the United States.
What Is an OTC Product?
An Over-the-Counter (OTC) product is a non-prescription drug that consumers can purchase directly without obtaining a prescription from a healthcare professional.
Unlike standard cosmetics, OTC products are intended to achieve specific physiological effects or provide recognized health-related benefits.
Common examples include:
- Sunscreen products
- Anti-acne treatments
- Anti-perspirants
- Anti-cavity dental products
- Medicated skin treatments
- Certain first-aid products
These products are regulated under FDA drug regulations rather than cosmetic regulations.
The Difference Between Cosmetics and OTC Products
One of the most important regulatory concepts in the United States involves product classification.
A cosmetic is generally intended to:
- Clean the body
- Beautify the appearance
- Enhance attractiveness
- Alter appearance without affecting bodily functions
Examples include:
- Moisturizers
- Makeup
- Perfumes
- Basic shampoos
- Body lotions
However, when a product claims to:
- Prevent disease
- Treat medical conditions
- Modify physiological functions
- Affect the body’s structure
the FDA may classify it as an OTC drug.
This classification is based not only on the formulation itself but also on marketing claims, packaging, advertising materials, and website content.
Why Product Claims Matter
Product claims often determine whether a product remains a cosmetic or becomes an OTC drug.
Consider the following examples:
Cosmetic Claim
“Improves the appearance of blemish-prone skin.”
OTC Drug Claim
“Treats acne.”
The first statement focuses on appearance, while the second suggests treatment of a medical condition.
Similarly:
Cosmetic Claim
“Helps skin feel protected outdoors.”
OTC Drug Claim
“Prevents sunburn.”
Because sunburn prevention is a recognized health claim, sunscreen products are generally regulated as OTC drugs in the United States.
Small wording differences can therefore create major regulatory consequences.
Common Categories of OTC Products
Several product categories frequently fall under FDA OTC regulations.
Sunscreen Products
Products containing SPF claims are among the most common OTC products.
Manufacturers must comply with specific FDA monograph requirements relating to:
- Approved active ingredients
- SPF testing
- Broad spectrum claims
- Product labelling
Acne Treatments
Products intended to treat acne are regulated as OTC drugs.
Common active ingredients include:
- Salicylic acid
- Benzoyl peroxide
Claims must align with the applicable OTC monograph requirements.
Anti-Perspirants
Unlike deodorants that merely control odour, anti-perspirants affect sweat production and therefore fall under OTC regulations.
Oral Care Products
Certain toothpastes and dental products intended to prevent cavities are also regulated as OTC drugs.
These categories represent only a small portion of the broader OTC landscape.
Understanding FDA OTC Monographs
A central concept in US OTC regulation is the OTC Monograph System.
An OTC monograph functions similarly to a regulatory rulebook that defines:
- Approved active ingredients
- Permitted concentrations
- Acceptable dosage forms
- Required claims
- Mandatory warnings
- Labelling requirements
If a product complies fully with an applicable OTC monograph, it can generally be marketed without undergoing a separate FDA pre-market approval process.
This pathway significantly simplifies market access while maintaining regulatory oversight.
Product Development Considerations
Regulatory compliance should begin during product development rather than after formulation is complete.
Companies entering the US market should evaluate:
- Product classification
- Active ingredient eligibility
- Monograph applicability
- Labelling requirements
- State-specific restrictions
- Manufacturing obligations
Early regulatory review often prevents costly reformulation and delays later in the process.
OTC Product Labelling Requirements
FDA OTC labelling requirements are significantly more detailed than standard cosmetic labelling requirements.
Labels typically must include:
- Product identity
- Net contents declaration
- Active ingredients
- Purpose statement
- Directions for use
- Warnings and precautions
- Inactive ingredients
- Manufacturer information
The well-known “Drug Facts” panel is one of the most recognizable elements of OTC product packaging.
Failure to comply with FDA labelling requirements may result in products being considered misbranded.
Scientific Substantiation of Product Claims
FDA regulations require that product claims be supported by appropriate scientific evidence.
Manufacturers should be able to demonstrate:
- Product performance
- Safety data
- Efficacy evidence
- Testing results
- Technical documentation
Unsupported claims can trigger enforcement actions, consumer complaints, and legal challenges.
Robust claim substantiation is therefore a critical component of OTC compliance strategies.
Manufacturing Requirements for OTC Products
OTC products must be manufactured under stringent quality standards.
Key expectations include:
- Good Manufacturing Practices (GMP)
- Quality management systems
- Production controls
- Documentation systems
- Product traceability
- Corrective action procedures
FDA inspectors may review manufacturing facilities to verify compliance with applicable requirements.
For many companies, manufacturing compliance represents one of the most significant investments required for OTC market entry.
FDA Establishment Registration
Manufacturing facilities involved in OTC drug production must generally register with the FDA.
Establishment registration helps authorities maintain oversight of facilities producing regulated products.
Companies must ensure that:
- Facilities are properly registered
- Registration information remains current
- Regulatory obligations are maintained annually
Failure to maintain registrations can create significant compliance issues and impact market access.
FDA Product Listing Requirements
In addition to facility registration, OTC products must also be listed with the FDA.
Product listing requirements typically include:
- Product identification details
- Active ingredients
- Label information
- Manufacturing details
- Regulatory classifications
Maintaining accurate product listings is an ongoing compliance obligation rather than a one-time administrative task.
State-Level Requirements Cannot Be Ignored
Federal FDA requirements are only part of the compliance picture.
Certain states impose additional obligations.
One of the best-known examples is California Proposition 65, which introduces additional warning requirements for specific substances.
Companies selling products nationally must therefore evaluate:
- Federal regulations
- State-specific requirements
- Emerging legislative developments
Ignoring state-level obligations can create compliance risks even when FDA requirements have been met.
Post-Market Compliance Responsibilities
Regulatory obligations continue long after a product reaches consumers.
Manufacturers must maintain ongoing compliance through:
- Adverse event monitoring
- Consumer complaint management
- Safety investigations
- Product quality reviews
- Regulatory updates
- Market surveillance activities
Post-market compliance plays a critical role in protecting both consumers and brand reputation.
Why OTC Regulatory Expertise Matters
The distinction between cosmetics and OTC products is one of the most misunderstood aspects of US regulatory compliance.
Successful market entry requires expertise in:
- FDA regulations
- OTC monographs
- Product classification
- Claim substantiation
- Labelling compliance
- GMP requirements
- Establishment registration
- Product listing
- Post-market obligations
At CE.way, we help manufacturers and brand owners navigate the complex world of FDA OTC regulations, supporting product development, classification, labelling, registrations, compliance strategies, and ongoing regulatory management to ensure successful access to the US market.
